Yoga for Painful Chemotherapy-Induced Peripheral Neuropathy: A Pilot, Randomized-Controlled Study

This research study will examine the feasibility of conducting an eight-week yoga
intervention for individuals with chronic painful chemotherapy-induced peripheral neuropathy.
The investigators will also explore participants' perceptions of acceptability and
satisfaction with the yoga intervention. Lastly, the investigators will examine changes in
chemotherapy-induced peripheral neuropathy severity, physical function, sleep-related
impairment, fatigue, anxiety, depression, pain, and salivary cortisol following the
eight-week yoga intervention.

Inclusion Criteria:

-≥18 years of age,

- self-report ≥ 4/10 (& ≤ 9/10 maximum) worst chemotherapy-induced peripheral neuropathy
pain over the past week,

- at least three months post neurotoxic chemotherapy completion

- signed informed consent,

- willingness to participate in all study activities

- speak/read English

Exclusion Criteria:

- prognosis of less than three months,

- documented peripheral neuropathy due to other causes (e.g., diabetes),

- planned receipt of neurotoxic chemotherapy during the study period,

- practice yoga >2 hours per week over the past six months,

- diagnosis or documented recent history of significant psychiatric comorbidity (i.e.,
psychosis, suicidal ideation, or substance abuse)

- clinician deems that the patient is physically/functionally unable to participate in a
yoga program